DESIGN THERAPEUTICS INC's ticker is DSGN and the CUSIP is 25056L103. A total of 44 filers reported holding DESIGN THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,053 | -69.3% | 2,565 | -18.0% | 0.00% | – |
| Q2 2023 | $19,747 | +9.5% | 3,127 | 0.0% | 0.00% | – |
| Q1 2023 | $18,027 | -43.8% | 3,127 | 0.0% | 0.00% | – |
| Q4 2022 | $32,083 | -38.3% | 3,127 | 0.0% | 0.00% | – |
| Q3 2022 | $52,000 | +15.6% | 3,127 | -3.7% | 0.00% | – |
| Q2 2022 | $45,000 | +9.8% | 3,247 | +28.0% | 0.00% | – |
| Q1 2022 | $41,000 | -22.6% | 2,536 | +3.0% | 0.00% | – |
| Q4 2021 | $53,000 | +178.9% | 2,463 | +93.0% | 0.00% | – |
| Q3 2021 | $19,000 | -26.9% | 1,276 | 0.0% | 0.00% | – |
| Q2 2021 | $26,000 | -98.6% | 1,276 | -97.9% | 0.00% | -100.0% |
| Q1 2021 | $1,830,000 | – | 60,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SR ONE CAPITAL MANAGEMENT, LP | 6,526,476 | $41,116,799 | 17.73% |
| Logos Global Management LP | 2,797,501 | $17,624,256 | 2.40% |
| Cormorant Asset Management, LP | 5,150,000 | $32,445,000 | 1.82% |
| RA Capital Management | 2,971,231 | $18,718,755 | 0.35% |
| Avoro Capital Advisors LLC | 3,500,000 | $22,050,000 | 0.30% |
| RTW INVESTMENTS, LP | 1,563,031 | $9,847,095 | 0.19% |
| GSA CAPITAL PARTNERS LLP | 238,200 | $1,501 | 0.15% |
| Virtus ETF Advisers LLC | 20,137 | $126,863 | 0.08% |
| Rock Springs Capital Management LP | 460,391 | $2,900,463 | 0.07% |
| Corton Capital Inc. | 17,323 | $109,135 | 0.05% |